Modeling and Simulation Archives

Publication

Oxford Academic, Neuro-Oncology Pediatrics – BRAF pub: Growth recovery in patients with BRAF-altered pediatric low-grade glioma following treatment with tovorafenib

This publication reports a pooled retrospective analysis evaluating growth patterns in children with B-Raf proto-oncogene…

Dorottya Gui-BodnarMay 28, 2026

Webinar

The Modeling Advantage: How Forward-Thinking Sponsors Are Moving Faster, De-Risking Earlier, and Winning with Regulators

CertaraMay 26, 2026

Blog

Certainty US 2026 recap: advancing model-informed drug development right from the start

This blog shares the highlights of our US Certainty event and explains how AI-enabled approaches…

CertaraMay 26, 2026

Publication

Population Pharmacokinetic Modeling of Niraparib to Assess Different Absorption Models

This publication describes the development of an updated population pharmacokinetic (PopPK) model for niraparib, a…

CertaraMay 21, 2026

Poster

Quantitative Systems Pharmacology Modeling of Atopic Dermatitis to Predict Biologic Therapy Response

Explore a quantitative systems pharmacology (QSP) model of atopic dermatitis calibrated to clinical trial data.

CertaraMay 21, 2026

Guide

How to Leverage PBPK Modeling and Simulation in Drug Research and Development

Learn how PBPK modeling and simulation in drug research and development reduces clinical burden, supports…

CertaraMay 12, 2026

Poster

Predicting FcRn-Mediated PK/PD with PBPK Modeling

Learn how PBPK modeling predicts FcRn binder PK/PD and IgG dynamics across species.

CertaraMay 12, 2026

Poster

Predicting Ocular Drug Behavior with PBPK Modeling

Learn how PBPK modeling predicts ocular drug exposure and target occupancy to optimize anti-VEGF therapies…

CertaraMay 12, 2026

Poster

Advancing In Vivo CAR-T with QSP

Learn how QSP modeling improves first-in-human dose selection for CAR-T therapies, enabling better translation and…

CertaraMay 12, 2026

Video

Certara IQ™ Demo

Watch a short demo of Certara IQ™, a QSP platform for modeling, simulation, and analysis.…

CertaraMay 12, 2026

Modeling and Simulation

Oxford Academic, Neuro-Oncology Pediatrics – BRAF pub: Growth recovery in patients with BRAF-altered pediatric low-grade glioma following treatment with tovorafenib

The Modeling Advantage: How Forward-Thinking Sponsors Are Moving Faster, De-Risking Earlier, and Winning with Regulators

Certainty US 2026 recap: advancing model-informed drug development right from the start

Population Pharmacokinetic Modeling of Niraparib to Assess Different Absorption Models

Quantitative Systems Pharmacology Modeling of Atopic Dermatitis to Predict Biologic Therapy Response

How to Leverage PBPK Modeling and Simulation in Drug Research and Development

Predicting FcRn-Mediated PK/PD with PBPK Modeling

Predicting Ocular Drug Behavior with PBPK Modeling

Advancing In Vivo CAR-T with QSP

Certara IQ™ Demo

Newsletter sign up

Quick links

Solutions

Contact